Company: FENC
Filing Date: 2025-06-03
Form Type: 8-K
Source: 0001104659-25-055992
Chunk: 0

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-06-03
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission of Matters to a Vote of Security Holders.  

On June 3, 2025, Fennec Pharmaceuticals
Inc. (the “ Company”) held an annual meeting of shareholders (the “ Meeting”). The shareholders approved all proposals
considered at the Meeting and approved all nominees of the Company for director, as follows:

1. The following five (6) nominees were elected to serve as directors, each to serve until the next annual meeting of shareholders
of the Company or until their respective successor shall have been duly elected or duly approved:

  Name of Nominee        Votes For      Votes Withheld      Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────────────
  Dr. Khalid Islam      13,432,561             304,760             5,580,283  
  Chris A. Rallis       13,808,792             354,099             5,580,283  
  Marco Brughera        13,807,501             355,390             5,580,283  
  Jodi Cook             13,259,894             902,997             5,580,283  
  Rostislav Raykov      13,432,561             730,330             5,580,283  
  Jeffrey Hackman       13,495,309             687,582             5,580,283  

2. The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board
of Directors to fix their remuneration was approved based on the following vote:

  Votes For             19,673,487  
  Votes Withheld            69,405  
  Votes Against                282  
  Broker Non-Votes               0  

3. The resolution to vote on the advisory vote on executive compensation was approved based on the following vote:

  Votes For             12,110,598  
  Votes Against          1,595,423  
  Abstentions              456,870  
  Broker Non-Votes       5,580,283  

4. The
resolution to vote on the proposed amendment to the 2020 Equity Incentive Plan was approved based on the following vote:

  Votes For             12,927,131  
  Votes Against            776,907  
  Abstentions              458,853  
  Broker Non-Votes